CN
Product Service Prevention BGI Hereditary Cancer Auxiliary Diagnosis Test
Are cancers really hereditary?
Authoritative international medical studies have demonstrated that around 5%-10% of malignant cancers are hereditary and that a parent generally has a 50% chance of passing on a causative gene to his or her offspring. Therefore, some hereditary cancers may occur in families.

Genes associated with hereditary cancers can be tested to identify whether an individual carries gene mutations associated with hereditary cancers, and to assess the individual' s risk of developing cancers, based on which a feasible risk management plan is developed to achieve early diagnosis, intervention, and treatment of cancers.



BGI Hereditary Cancer Auxiliary Diagnosis Test
High-throughput sequencing is performed on the subject's DNA sample extracted from saliva or blood. A single test can detect mutations in 23 hereditary cancer-associated genes in men and 24 genes in women. The test results, along with the subject's family history and other relevant information, can provide information on the risk of developing hereditary cancers, and enable the development of an adequate health management and early intervention plan for the future.


Male Package (23 types of cancers)
  • Colorectal carcinoma

    Prostate cancer

    Gastric cancer

    Esophageal cancer

    Renal cancer

    Bladder cancer

    Urothelial carcinoma

    Pancreatic cancer

    Gastrointestinal stromal carcinoma

    Thyroid cancer

    Parathyroid cancer

    Breast cancer

    Melanoma

    Tuberous sclerosis

    Pheochromocytoma

  • Familial nephroblastoma
    Multiple endocrine neoplasia
    Retinoblastoma
    Nevoid basal cell carcinoma
    Mulitiple osteochondroma
    Multiple neurofibroma
    Familial paraganglioma
    Familial neuroblastoma
Female Package (24 types of cancers)
  • Breast cancer

    Ovarian cancer

    Endometrial cancer

    Colorectal carcinoma

    Gastric cancer

    Esophageal cancer

    Renal cancer

    Bladder cancer

    Urothelial carcinoma

    Pancreatic cancer

    Gastrointestinal stromal carcinoma

    Thyroid cancer

    Parathyroid cancer

    Melanoma

    Tuberous sclerosis

    Pheochromocytoma

  • Familial nephroblastoma
    Multiple endocrine neoplasia
    Retinoblastoma
    Nevoid basal cell carcinoma
    Mulitiple osteochondroma
    Multiple neurofibroma
    Familial paraganglioma
    Familial neuroblastoma
Product features
Testing Purpose
Suitable For
  • Oncology Patients

    (who meet any of the following criteria)

    Breast cancer, ovarian cancer, colorectal cancer and rare cancers, among others.

    Early age of onset (<50 years of age)

    Multiple primary malignancies

    Family history of cancer

  • People with a family
    history of cancer

    (who meet any of the following criteria)

    Three relatives with similar or identical cancer

    Presence of oncology patients among 2 generations of relatives

    Presence of one young oncology patient (<50 years of age) in the family

Sample Type
  • Blood

    5mL of blood
    (collected in EDTA anticoagulant tubes)

  • Saliva

    2mL of saliva

Customer Service:

+1 866 301 0097

Service Time:7*24

Language:English

E-mail: info@bgi.com

Copyright © BGI 2022. All Rights Reserved. Guangdong ICP Registration No. 16021117